Wize Pharma Inc (OTCMKTS:WIZP) Chairman Noam Danenberg joins Steve Darling of Proactive Investors at the 9th Annual LD Micro Invitational Investor Conference in Los Angeles, CA. Wize Pharma is a clinical-stage biopharmaceutical company. The Israeli company is focused on the treatment of ophthalmic disorders.
Wize Pharma Inc shows it's LO2A Eye Drops, which treat Dry Eye syndrome
Quick facts: Wize Pharma, Inc.
Price: 0.16 USD
Market Cap: $1.76 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE